Literature DB >> 18685555

Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008.

Anthony E Fiore1, David K Shay, Karen Broder, John K Iskander, Timothy M Uyeki, Gina Mootrey, Joseph S Bresee, Nancy S Cox.   

Abstract

This report updates the 2007 recommendations by CDC's Advisory Committee on Immunization Practices (ACIP) regarding the use of influenza vaccine and antiviral agents (CDC. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices [ACIP]. MMWR 2007;56[No. RR-6]). The 2008 recommendations include new and updated information. Principal updates and changes include 1) a new recommendation that annual vaccination be administered to all children aged 5--18 years, beginning in the 2008--09 influenza season, if feasible, but no later than the 2009--10 influenza season; 2) a recommendation that annual vaccination of all children aged 6 months through 4 years (59 months) continue to be a primary focus of vaccination efforts because these children are at higher risk for influenza complications compared with older children; 3) a new recommendation that either trivalent inactivated influenza vaccine or live, attenuated influenza vaccine (LAIV) be used when vaccinating healthy persons aged 2 through 49 years (the previous recommendation was to administer LAIV to person aged 5--49 years); 4) a recommendation that vaccines containing the 2008--09 trivalent vaccine virus strains A/Brisbane/59/2007 (H1N1)-like, A/Brisbane/10/2007 (H3N2)-like, and B/Florida/4/2006-like antigens be used; and, 5) new information on antiviral resistance among influenza viruses in the United States. Persons for whom vaccination is recommended are listed in boxes 1 and 2. These recommendations also include a summary of safety data for U.S. licensed influenza vaccines. This report and other information are available at CDC's influenza website (http://www.cdc.gov/flu), including any updates or supplements to these recommendations that might be required during the 2008--09 influenza season. Vaccination and health-care providers should be alert to announcements of recommendation updates and should check the CDC influenza website periodically for additional information.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18685555

Source DB:  PubMed          Journal:  MMWR Recomm Rep        ISSN: 1057-5987


  299 in total

Review 1.  Oseltamivir in seasonal, avian H5N1 and pandemic 2009 A/H1N1 influenza: pharmacokinetic and pharmacodynamic characteristics.

Authors:  Nicolas Widmer; Pascal Meylan; Anton Ivanyuk; Manel Aouri; Laurent A Decosterd; Thierry Buclin
Journal:  Clin Pharmacokinet       Date:  2010-11       Impact factor: 6.447

2.  Disparities in influenza vaccine coverage in the United States, 2008.

Authors:  Shauna T Linn; Jack M Guralnik; Kushang V Patel
Journal:  J Am Geriatr Soc       Date:  2010-06-01       Impact factor: 5.562

3.  Analysis of in vivo dynamics of influenza virus infection in mice using a GFP reporter virus.

Authors:  Balaji Manicassamy; Santhakumar Manicassamy; Alan Belicha-Villanueva; Giuseppe Pisanelli; Bali Pulendran; Adolfo García-Sastre
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-07       Impact factor: 11.205

Review 4.  Inactivated influenza vaccines: recent progress and implications for the elderly.

Authors:  Valentina Parodi; Daniela de Florentiis; Mariano Martini; Filippo Ansaldi
Journal:  Drugs Aging       Date:  2011-02-01       Impact factor: 3.923

5.  A simple method for amplifying RNA targets (SMART).

Authors:  Stephanie E McCalla; Carmichael Ong; Aartik Sarma; Steven M Opal; Andrew W Artenstein; Anubhav Tripathi
Journal:  J Mol Diagn       Date:  2012-06-11       Impact factor: 5.568

6.  Routine immunization of adults in Canada: Review of the epidemiology of vaccine-preventable diseases and current recommendations for primary prevention.

Authors:  Michael D Parkins; Shelly A McNeil; Kevin B Laupland
Journal:  Can J Infect Dis Med Microbiol       Date:  2009       Impact factor: 2.471

7.  Immunogenicity associated with the routine use of an influenza A H1N1 vaccine in health care personnel in Guangzhou, China.

Authors:  Biao Di; Xinhong Xu; Tiegang Li; Enjie Lu; Jibin Wu; Yanhui Liu; Yiyun Chen; Sam Pickerill; Ming Wang
Journal:  Clin Vaccine Immunol       Date:  2010-07-14

8.  A Bayesian network model for analysis of detection performance in surveillance systems.

Authors:  Masoumeh Izadi; David Buckeridge; Anna Okhmatovskaia; Samson W Tu; Martin J O'Connor; Csongor Nyulas; Mark A Musen
Journal:  AMIA Annu Symp Proc       Date:  2009-11-14

9.  Protecting young babies from influenza.

Authors:  N Macdonald; R Bortolussi
Journal:  Paediatr Child Health       Date:  2009-11       Impact factor: 2.253

10.  Seasonal Influenza Vaccination of Children Induces Humoral and Cell-Mediated Immunity Beyond the Current Season: Cross-reactivity With Past and Future Strains.

Authors:  Adrian J Reber; Jin Hyang Kim; Laura A Coleman; Sarah M Spencer; Jessie R Chung; Jufu Chen; Paul Gargiullo; Maria E Sundaram; Edward A Belongia; David K Shay; Jacqueline M Katz; Suryaprakash Sambhara
Journal:  J Infect Dis       Date:  2016-08-28       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.